ArticleClinical cancer research : an official journal of the American Association for Cancer Research2019

Phase I Study of a CD45-Targeted Antibody-Radionuclide Conjugate for High-Risk Lymphoma.

Ryan D Cassaday et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.